Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients Publisher Pubmed

Tahamtan A^{1, 2} ; Tavakoliyaraki M³ ; Salimi V⁴

Source: Expert Review of Respiratory Medicine Published:2020

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus, Viral Immunology (2018)

2. Effects of Cannabinoid Receptor Type 2 in Respiratory Syncytial Virus Infection in Human Subjects and Mice, Virulence (2018)

3. Functional Variation (Q63r) in the Cannabinoid Cb2 Receptor May Affect the Severity of Covid-19: A Human Study and Molecular Docking, Archives of Virology (2021)

Experts (# of related papers)

View all Related Experts

Vahid Salimi (13)

Fazel Shokri (4)

Other Related Docs

4. Respiratory Syncytial Virus Infection: Why Does Disease Severity Vary Among Individuals?, Expert Review of Respiratory Medicine (2020)

5. Disease Severity in Respiratory Syncytial Virus Infection: Role of Host Genetic Variation, Reviews in Medical Virology (2019)

6. Blocking of Opioid Receptors in Experimental Formaline-Inactivated Respiratory Syncytial Virus (Fi-Rsv) Immunopathogenesis: From Beneficial to Harmful Impacts, Medical Microbiology and Immunology (2018)

7. Effects of Cannabinoids and Their Receptors on Viral Infections, Journal of Medical Virology (2016)

8. Opioids and Viral Infections: A Double-Edged Sword, Frontiers in Microbiology (2016)

9. Anti-Inflammatory Effects of Curcumin-Loaded Niosomes on Respiratory Syncytial Virus Infection in a Mice Model, Journal of Medical Microbiology (2022)

10. Hyperglycemia Results in Decreased Immune Cell Infiltration and Increased Viral Load in the Lung in a Mouse Model of Rsv Infection, Cytokine (2021)

11. The Strengths and Limits of Cannabinoids and Their Receptors in Cancer: Insights Into the Role of Tumorigenesis-Underlying Mechanisms and Therapeutic Aspects, Biomedicine and Pharmacotherapy (2021)

12. Beyond Prediction: Unveiling the Prognostic Power of Μ-Opioid and Cannabinoid Receptors, Alongside Immune Mediators, in Assessing the Severity of Sars-Cov-2 Infection, BMC Infectious Diseases (2024)

13. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)

14. Neutrophils in Respiratory Syncytial Virus Infection: From Harmful Effects to Therapeutic Opportunities, British Journal of Pharmacology (2021)

15. Covid-19 Infection and Liver Injury: Clinical Features, Biomarkers, Potential Mechanisms, Treatment, and Management Challenges, World Journal of Clinical Cases (2021)

16. Analyzing Trends in Demographic, Laboratory, Imaging, and Clinical Outcomes of Icu-Hospitalized Covid-19 Patients, Canadian Journal of Infectious Diseases and Medical Microbiology (2023)

17. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)

18. Neutrophil to Lymphocyte Ratio (Nlr) and Derived Nlr Combination: A Cost-Effective Predictor of Moderate to Severe Covid-19 Progression, Iranian Journal of Allergy# Asthma and Immunology (2022)

19. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)

20. Clinical Characteristics of Fatal Cases of Covid-19 in Tabriz, Iran: An Analysis of 111 Patients, Frontiers in Emergency Medicine (2021)

Style	Citing Format
MLA	Tahamtan A, Tavakoliyaraki M, Salimi V. "Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients." Expert Review of Respiratory Medicine, vol. 14, no. 10, 2020, pp. 965-967.
APA	Tahamtan A, Tavakoliyaraki M, Salimi V (2020). Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients. Expert Review of Respiratory Medicine, 14(10), 965-967.
Chicago	Tahamtan A, Tavakoliyaraki M, Salimi V. "Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients." Expert Review of Respiratory Medicine 14, no. 10 (2020): 965-967.
Harvard	Tahamtan A, Tavakoliyaraki M, Salimi V (2020) 'Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients', Expert Review of Respiratory Medicine, 14(10), pp. 965-967.
Vancouver	Tahamtan A, Tavakoliyaraki M, Salimi V. Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients. Expert Review of Respiratory Medicine. 2020;14(10):965-967.
BibTex	@article{ author = {Tahamtan A and Tavakoliyaraki M and Salimi V}, title = {Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients}, journal = {Expert Review of Respiratory Medicine}, volume = {14}, number = {10}, pages = {965-967}, year = {2020} }
RIS	TY - JOUR AU - Tahamtan A AU - Tavakoliyaraki M AU - Salimi V TI - Opioids/Cannabinoids As a Potential Therapeutic Approach in Covid-19 Patients JO - Expert Review of Respiratory Medicine VL - 14 IS - 10 SP - 965 EP - 967 PY - 2020 ER -